NCT03630822View on ClinicalTrials.gov

Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder

NACompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

May 10, 2021

Study Completion Date

January 2, 2022

Conditions
SchizophreniaBipolar I Disorder
Interventions
BEHAVIORAL

Psychiatric Advanced Directive

The patient completes a questionnaire to express in advance his wishes regarding his future care in psychiatry.

BEHAVIORAL

Standard care

standardized maintenance with the patient

Trial Locations (1)

13354

Assistance Publique Hôpitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT03630822 - Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder | Biotech Hunter | Biotech Hunter